Skip to main content
Premium Trial:

Request an Annual Quote

University in Hong Kong Forms Co. to Distribute Genomic Technologies

Premium

H

ONG KONG--City University of Hong Kong has formed Advanced Genomic Technologies, a biotech company that will use genomics and biochip technologies to develop diagnostic and therapeutic products for human diseases. The company’s core technologies will be DNA chips and internet-based bioinformatic resources to elucidate gene functions and provide toxicogenomics and pharmacogenomics databases for traditional Chinese medicine.

The university developed its own DNA chip technology over the past four years using a $4.5 million Industry Support Fund from the Hong Kong SAR Government Industry Department. The company has raised $50 million in seed financing, led by China International Investment here and Xieli Group of Ningbo, China.

The initial focus of the company will be in the fields of genetic disorders, infectious diseases, and cancers.

Filed under

The Scan

Booster for At-Risk

The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people 65 and older or at increased risk.

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.